Seleccione otro país
Bienvenido a Lyxor España
Por favor, lea la información importante aquí incluida antes de continuar a nuestra página web

Información relevante 

Los ETF UCITS que figuran en este sitio web son fondos con denominación Amundi ETF y Lyxor ETF.

Los Lyxor ETFs presentados en la página web de, pueden ser objeto de restricciones en lo que respecta a la inversión por determinadas personas o en determinados países, en virtud de las distintas regulaciones nacionales aplicables a dichas personas o en dichos países. Cualquier persona que acceda a esta página web desde una jurisdicción en la cual se aplican dichas restricciones tiene que informarse al respecto y observar dichas restricciones. Por consiguiente, le corresponde a usted asegurarse de que, efectivamente está autorizado a invertir en los Lyxor ETFs presentados en esta página web. Invirtiendo en estos productos, usted garantiza a Société Générale que está efectivamente autorizado a invertir. Inversores españoles se deben dirigir a

La información contenida en esta página web no constituye una oferta o invitación para adquirir o vender los productos aquí descritos a personas sometidas a  jurisdicciones donde:

(a) dicha oferta o invitación no esté autorizada;
(b) Lyxor Asset Management no esté cualificada para hacer dicha oferta o invitación;
(c)  sea ilícito hacer dicha oferta o invitación.

Los ETFs referidos en esta página web no han estado y no estarán registrados conforme al U.S Securities Act de1933, por lo tanto, no pueden ser ofertados ni vendidos en los EE.UU sin registro previo o solo en caso de excepción de registro conforme al  al Securities Act. Por consiguiente, los ETFs listados en esta página web no pueden ser vendidos a “U.S persons”, ni transferidos a los Estados Unidos a menos que dicha transacción esté sujeta a los requisitos de registro conforme a la ley Americana.

Esta página web es de carácter comercial y no de carácter legal. No se garantiza la exactitud, exhaustividad o pertinencia de la información aunque ha sido establecida a partir de fuentes consideradas como fiables. La información presentada en esta página web se basa en información de mercado constada en un momento dado que puede variar con posterioridad a su publicación. El valor de reembolso de los Lyxor ETFs puede ser inferior al montante de la inversión inicial. En el peor de los casos, los inversores podrían perder hasta la totalidad de su inversión, por lo que se recomienda a los inversores consultar la sección« factores de riesgo » del folleto del producto. El precio de algunos Lyxor ETFs puede ser sensible a riesgos de tipo de cambio entre la cotización del ETF y/o la divisa del índice y/o la divisa del componente del índice.

Todos los LyxorETFs presentados en esta página web han sido aprobados por la “Autorité des Marchés Financiers (AMF)” y son objeto de un folleto aprobado por la AMF y pasaporteado en la CNMV conforme a la Directiva 2003/71/CE. Dichos folletos están disponibles en esta página Web.

La documentación relativa a los Lyxor ETFs preverá métodos de ajuste y de sustitución para tener en cuenta que consecuencias tendría cualquier suceso extraordinario que afecte a uno o varios de los subyacentes de estos productos.

Antes de invertir en un Lyxor ETF, usted debe hacer su propia valoración del riesgo desde un punto de vista legal, fiscal y  contable, sin depender exclusivamente de la información que le proporcionamos y consultando, si lo estima necesario, sus propios asesores en la materia o cualquier otro asesor independiente.

El inversor de ETFs estará expuesto a los siguientes factores de riesgo: Riesgo de pérdida del capital invertido, al no existir ninguna garantía, como consecuencia de un movimiento desfavorable del Índice de Referencia, Riesgo de que el objetivo de gestión solo se cumpla parcialmente, Riesgo de contrapartida como resultado de la utilización de los instrumentos financieros (OTC) formalizados con un establecimiento de crédito. Se recomienda a los inversores que consulten la sección del folleto antes de invertir.

En la medida en que cumpla con la legislación aplicable, ninguna entidad del Grupo Société Générale acepta responsabilidad alguna por las consecuencias financieras o de cualquier otra naturaleza que resulten de la inversión en este producto.

Tenemos un nuevo hogar

Banner Amundi

Leer más
16 oct 2017

Q4 2017 Outlook: The fairytale continues

At the start of last quarter we considered whether the fairytale of strong performance from equity and bond markets alike could continue. Well... it has so far. But what can we expect for Q4?

Will they all live happily ever after? 

There’s no doubt economic growth has been a plus point this year, with 2017 Bloomberg consensus estimates for the US and eurozone revised up to over 2% and to 1.5% for Japan. Yet low inflation is proving a much trickier problem to remedy across the developed world. 

In all likelihood, central banks will only normalise their monetary policies gradually over the coming months, so there should be no rapid removal of the support they’ve been providing the financial markets. Risk assets are expensive, but as long as economic growth maintains its pace a major correction looks unlikely. And that’s good news for investors.

But where exactly do the best opportunities lie over the coming months?

No bond bonanza

With wage and core inflation expected to pick up in the US over the medium term, the Fed looks likely to stay the course when it comes to normalising its monetary policy. It’s ready to start shrinking its balance sheet in October and a rate hike is pencilled in for December, so we’re slightly underweight treasuries. And with the ECB set to taper slowly throughout 2018 we’re also slightly underweight bunds.

Hop into high yield

European high yield credit remains an interesting option for the less risk-averse bond investor, although historically tight spreads do sound a note of caution. We’re overweight high yield as fundamentals look supportive and we see little chance of a reversal over the next few months.

Full steam ahead for eurozone equities

The relatively poor performance of eurozone equities last quarter was puzzling, but probably due to profit-taking after a period of double-digit gains. The asset class is still trading at a considerable discount to US equities and, with reflation in full swing, we expect foreign and domestic investors to pile back into eurozone equities this quarter, resulting in renewed rises. We’d advocate being selective though; some areas should do better than others. 

Choosing the best areas within the eurozone

Banks continue to heal and should benefit from reflation, while the construction sector looks interesting not only because it’s cheap, but because it should benefit from a pick-up in real estate and infrastructure investment.  Conditions look ripe for households to increase their spending beyond their basic needs, so we still prefer discretionary to staples.

At the country level, we’re big fans of “Macronomics”, hence our slight preference for French rather than German stocks. And, after their long-term underperformance, we also like Greek equities as we believe the eurozone is determined to find a solution to the country’s debt problems.

A selective approach to US equities

The S&P 500 has hit record highs, so there’s no denying US equity valuations are looking even more stretched than they were last quarter. What’s more, they’re vulnerable to the Fed’s balance sheet reduction. And yet fundamentals remain impressive and some risks have passed – for now at least it looks less likely the Trump presidency will fail. The debt ceiling has been raised, and there’s plenty of time to pass tax reform.

With these conflicting drivers, we’re neutral on US equities. But delving deeper we favour some areas of the market over others: for instance, we prefer large-caps over their smaller peers and domestic-focused stocks. We’re bullish on banks over the long term, but low inflation could prove a headwind in Q4.

Overweight Japanese equities for the long run

With the economy on the mend, the Bank of Japan has no reason to alter its accommodative stance. This, combined with foreign investment at low levels, has led us to upgrade our long-term stance towards Japanese equities to positive.

We can’t however recommend a headlong rush into Japan just yet, so it’s more of a tactical play for now. EPS growth is slightly slower than we’d like and the North Korean nuclear threat remains a worry. Yet, periods of renewed yen weakness could offer interesting windows for outperformance.

Go easy on emerging equities

Emerging equities posted some solid gains last quarter, but their performance could soften if Treasury yields rise – as we expect. We’re neutral on the asset class for now. South Korea (which has so far proven resilient to the threat from the North) is our preferred market.

Cautious on commodities

It’s an intricate picture for the price of oil. Risks include a possible increase in supply and a potential US dollar rebound. However, robust global growth should keep demand high while OPEC producers are unlikely to let prices fall far below USD 50 / barrel. Our expectation is for Brent to continue to trade within the USD 47–55 / barrel range, so we’re neutrally positioned.

Since we recommended buying copper last quarter its price has risen by 25%, making it look a lot less attractive for Q4. We’ve downgraded our stance to neutral. Gold also performed well last quarter, but we’re struggling to see catalysts for it to rise much further. We’re keeping it at neutral for hedging purposes. 



*Lyxor CAR,  October 2017.

Our key calls

our key calls

Key: U/W = underweight, O/W = overweight, s= soft, ST = short-term, LT = long-term

Source: Lyxor CAR, July 2017


All data sourced by: Lyxor & SG Cross Asset Research teams, Ocober  2017. Opinions expressed are as at 12 October 2017. 

This communication is for professional clients only.

This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets In Financial Instruments Directive 2004/39/EC.

This document is of a commercial nature and not of a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor International Asset Management or any of their respective affiliates or subsidiaries to purchase or sell the product referred to herein.

We recommend to investors who wish to obtain further information on their tax status that they seek assistance from their tax advisor. The attention of the investor is drawn to the fact that the net asset value stated in this document (as the case may be) cannot be used as a basis for subscriptions and/or redemptions. The market information displayed in this document is based on data at a given moment and may change from time to time. The figures relating to past performances refer or relate to past periods and are not a reliable indicator of future results. This also applies to historical market data. The potential return may be reduced by the effect of commissions, fees, taxes or other charges borne by the investor.

Lyxor International Asset Management (Lyxor ETF), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive and the AIFM Directive (2011/31/EU). Lyxor ETF is represented in the UK by Lyxor Asset Management UK LLP, which is authorised and regulated by the Financial Conduct Authority in the UK under Registration Number 435658.

Connect with us on linkedin